| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $532.4M | +17.6% |
| Cost of Revenue | $1.8M | +1.3% |
| Gross Profit | $208.5M | +31.0% |
| R&D Expense | $12.4M | -9.5% |
| SG&A Expense | $89.8M | +3.5% |
| Operating Income | $23.6M | +181.1% |
| Pre-tax Income | $19.3M | +163.1% |
| Income Tax | $9.3M | +488.7% |
| Net Income | $10.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.2M | -66.1% |
| Accounts Receivable | $16.8M | +320.9% |
| Current Assets | $354.5M | -7.3% |
| Total Assets | $1.16B | +3.8% |
| Current Liabilities | $96.0M | +22.2% |
| Long-term Debt | $68.5M | +1.0% |
| Total Liabilities | $229.5M | +9.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.4M | -174.4% |
| Capital Expenditures | $2.1M | +0.4% |
| Investing Cash Flow | -$48.4M | -204.7% |
| Financing Cash Flow | -$9.7M | -55.4% |
| Free Cash Flow | -$20.5M | -133.1% |
| +135.6% |
| EPS (Basic) | -$1.19 | +49.8% |
| EPS (Diluted) | -$1.19 | +49.8% |
| Stockholders' Equity |
| $588.4M |
| -2.9% |